The growth inhibitory effects of D-glucosamine hydrochloride (GlcNH 2 ⋅HCl), D-glucosamine (GlcNH 2 ) and N-acetyl glucosamine (NAG) on human hepatoma SMMC-7721 cells in vitro were investigated. The results showed that GlcNH 2 ⋅HCl and GlcNH 2 resulted in a concentration-dependent reduction in hepatoma cell growth as measured by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. This effect was accompanied by a marked increase in the proportion of S cells as analyzed by flow cytometry. In addition, human hepatoma SMMC-7721 cells treated with GlcNH 2 ⋅HCl resulted in the induction of apoptosis as assayed qualitatively by agarose gel electrophoresis. NAG could not inhibit the proliferation of SMMC-7721 cells. GlcNH 2 ⋅HCl exhibited antitumor activity against Sarcoma 180 in Kunming mice at dosage of 125~500 mg/kg, dose of 250 mg/kg being the best. GlcNH 2 ⋅HCl at dose of 250 mg/kg could enhance significantly the thymus index, and spleen index and could promote T lymphocyte proliferation induced by ConA. The antitumor effect of GlcNH 2 ⋅HCl is probably host-mediated and cytocidal.
INTRODUCTION
Chitin, a kind of poly-β(1,4)-N-acetyl-D-glucosamine, is a natural biopolymer present in the exoskeleton of crustaceans and in cell walls of fungi, insects and yeast. A series of oligomers and monosaccharides, such as GlcNH 2 and NAG, can be obtained by either chemical or enzymatic hydrolysis of chitin and chitosan (Akiyama et al., 1995) . Besides hydroxyl, there are other functional groups in GlcNH 2 and NAG, for example, amido and acetylamino. Many derivatives can thus be obtained from them, most of which are known to have various biological activities including antitumor activities , increased protective effects against infection by some pathogens (Martin et al., 2003; Wang and Chen, 2005) and antimicrobial activities (Chen, 2001) . Wang et al.(2003a; 2003b) reported that NAG, GlcNH 2 ⋅HCl and GlcNH 2 could induce proliferation of leukemia K562 cells and make them differentiate toward macrophage. GlcNH 2 at concentration of certain range could kill tumor cells without influencing normal cells (Friedman and Skehan, 1980) . It is therefore postulated that combination of GlcNH 2 with membrane-active drugs may have the potential to kill tumor cells, especially for neuro-oncology. Dong et al.(2004) reported that glucosamine sulphate could inhibit proliferation of leukemia HL60 cells and induce the differentiation of HL60 cells toward the granulocytic or monocytic lineage. In addition, glucosamine sulphate has been proved to be useful in the therapy of osteoarthritis (Reginster et al., 2001) .
However, there is no report on the direct cytotoxicity of D-glucosamine and its derivatives to human hepatoma cell. Moreover, there are only a few reports on the antitumor activity of D-glucosamine and its derivatives in murine models. Much controversy on its mechanism still exists. This study was aimed at investigating the inhibitory effects of GlcNH 2 ⋅HCl, GlcNH 2 and NAG on human hepatoma SMMC-7721 cells and the antitumor activity of GlcNH 2 ⋅HCl in Kunming mice implanted with solid tumor Sarcoma 180.
MATERIALS AND METHODS

Chemicals and reagents
D-glucosamine hydrochloride (GlcNH 2 ⋅HCl), D-glucosamine (GlcNH 2 ) and N-acetyl glucosamine (NAG) were prepared and purified (purity≥99%) by our lab according to previous methods (Ingle et al., 1973) . 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Concanavalin A (ConA) were purchased from Sigma Chemical Co. (USA). All other chemicals were analytical reagents.
Cells and culture
Human hepatoma cell line SMMC-7721 was procured from Shanghai Institute of Cell Biology, China. Kunming male mice (8-week-old) were obtained from the Shandong Academy of Medical Sciences. The cells were cultured in RPMI-1640 medium supplemented with 15% BCS, 100 U/ml penicillin and 100 U/ml streptomycin at 37 °C in a 5% CO 2 atmosphere and then seeded in 96-well plates (Costar) at initial density of (5~7)×10 5 cells/ml and incubated for 24 h, then treated with the test glucosamine samples at final concentration of 10~1000 µg/ml respectively. Untreated cells were used as controls. Microplates were incubated at 37 °C in a 5% CO 2 atmosphere for 24 to 120 h. At the indicated treatment times, observation and microphotography of cells were done by IX 70 inverted microscope (Olympus).
MTT cell viability assay
The cytotoxicity of glucosamine samples against SMMC-7721 cells in vitro was examined with MTT assay according to previously described procedures (Mosmann, 1983; Nakashima et al., 1989; Wilson et al., 1990 DNA extraction and agarose gel electrophoresis DNA was isolated as described previously (Sambrook and Russell, 2001 ). Briefly, SMMC-7721 cells treated with GlcNH 2 ⋅HCl, GlcNH 2 , NAG and untreated cells were collected and washed with icecold PBS. Then, the cells were lysed in a solution containing 50 mmol/L Tris-HCl (pH 8.0), 10 mmol/L EDTA, 10 mmol/L NaCl, 0.5% SDS and 0.5 mg/ml proteinase K and were incubated at 60 °C for 1 h. After the addition of RNase A (final concentration 0.25 mg/ml), the cells were incubated at 37 °C for 1 h. The lysate was extracted with equal volume of phenol/chloroform (1:1, v/v) and then precipitated with ethanol. The extracted DNA samples were dissolved in TE buffer and the amount of DNA equivalent to content of (3~5)×10 5 cells was electrophoresed at 50 V in 1% agarose gel. The presence of DNA in the gel was visualized by ethidium bromide and was photographed under UV illumination (YLN2K, YALIEN Co.).
Cell cycle analysis
After washing twice with PBS, cells ( 1×10 6 ) treated and untreated with GlcNH 2 ⋅HCl were fixed in 70% ice-cold ethanol immediately for 4 h. Fixed cells were washed in phosphate-buffered saline with 0.1% Triton-X and then stained with 20 µg/ml propidium iodide (Sigma, USA) and 200 U/ml RNase A (Lin et al., 1996) . The DNA content was measured by FACS Vantage Flow Cytometer (Becton Dickinson, USA) and analyzed by ModFit LT software.
In vivo antitumor activity assay
Sarcoma 180 tumor ascites (2×10 7~6 ×10 7 cells/ml) were subcutaneously inoculated into 8-week-old Kunming male mice armpit at 0.2 ml/mouse. The mice were divided randomly into control and GlcNH 2 ⋅HCl groups. GlcNH 2 ⋅HCl dissolved in saline was orally administered to the tu-mor-bearing mice once daily for 10 d at 24 h after tumor inoculation. The same volume of saline was orally administered to the control mice. The tumor was allowed to grow on the mice for 10 d before it was removed from the animal and weighed. The spleen and thymus of the mice were also removed and weighed to obtain the index of the spleen and thymus. The antitumor activity of GlcNH 2 ⋅HCl was expressed as an inhibition ratio calculated as [(A−B)/A]×100%, where A and B were the average tumor weights of the control and treated groups, respectively. Spleen index (mg/g)=spleen weight/body weight, thymus index (mg/g)=thymus weight/body weight.
Mitogenic response assay
For mitogenic response assay, splenic lymphocytes (8×10 6 per well) from tumor-bearing Kunming mice administered with indicated doses of GlcNH 2 ⋅HCl and the control mice were co-cultured in the presence of ConA (7.0 µg/ml) in 96-well culture plates for 72 h. Cytotoxicity to lymphocyte proliferation was examined by MTT assay. The cultures were incubated with 0.5 µg/ml MTT solution for the last 4 h incubation. Then, the supernatants of the cultures were mixed with 100 µl of dimethyl sulfoxide (DMSO). The absorbance of each well was measured by an ELISA reader (Multiscan MK3, Thermo Labsystems) using a test wavelength of 570 nm. The proliferation of lymphocyte=A−B, where A was the OD 570 of well with ConA, and B was the OD 570 of well without ConA.
Statistical analysis
Data are presented as the arithmetic mean± standard deviation (SD) of triplicate samples. Statistical analysis was performed using SPSS 10.0. ANOVA was used to analyze statistical comparisons between groups. Differences with P-values less than 0.05 were considered to be statistically significant.
RESULTS
Inhibitory effects of glucosamine samples on the proliferation of SMMC-7721 cells in vitro
It was found that control cells achieved a plateau phase after an incubation of 96 h. The cell viability at 120 h approximated that at 96 h. From 24 h to 72 h, the cell viability of SMMC-7721 treated with different concentrations of GlcNH 2 ⋅HCl and GlcNH 2 kept rising as the control, but the cell viability declined obviously after 72 h at concentrations of 500 µg/ml and 1000 µg/ml and became minimum at 120 h. The growth of cells treated with different concentrations of NAG was similar to that of the control. Fig.1 shows the inhibition of cell growth after treatment with GlcNH 2 ⋅HCl, GlcNH 2 and NAG at the concentrations of 10~1000 µg/ml for 120 h. Treatment with GlcNH 2 ⋅HCl and GlcNH 2 for 120 h resulted in a concentration-dependent inhibition in SMMC-7721 cell growth. The inhibition ratios against SMMC-7721 cells of GlcNH 2 ⋅HCl and GlcNH 2 at concentration of 500 µg/ml were 50% and 52%, and reached 82% and 83% at concentration of 1000 µg/ml, respectively. However, NAG hardly showed growth inhibition even at the concentration of 1000 µg/ml.
Changes in cell morphology
As shown in Figs.2a~2c, the control cell was morphologically hexagon-like, and its cytoplasm was clear. Adjacent cells were kept compact and there was no contact inhibition. Figs.2d~2i demonstrate the morphological changes in SMMC-7721 cells treated with GlcNH 2 ⋅HCl and GlcNH 2 at concentration of 1000 µg/ml. Cells turned fibriform after 72 h treatment. Many granules occurred in cytoplasm, and cell boundary became blurred after 120 h incubation. Besides fragments, agglomerate chromatin was also observed.
In contrast, the cell growth of NAG group was similar to that of the control as shown in Figs.2j~2l. 10 µg/ml 100 µg/ml 500 µg/ml 1000 µg/ml DNA fragmentation pattern DNA integrity of SMMC-7721 cells treated with 500 µg/ml GlcNH 2 ⋅HCl was analyzed to assess apoptosis. Fig.3 shows that these cells did not display the inter-mucleosomal DNA fragmentation pattern characteristic of apoptosis after incubation for 72~168 h. Lanes C-E contained DNA samples of GlcNH 2 ⋅HCl-treated cells and showed a slight smear.
Effect of GlcNH 2 ⋅HCl on cell cycle changes of SMMC-7721 cells
Cells treated with 500 µg/ml GlcNH 2 ⋅HCl for 72 h were arrested in S phase and had decreased number of cells in G2 phase (Table 1) . Increase in GlcNH 2 ⋅HCl concentration and treatment time may increase the percentage of cells with apoptotic DNA content measurement (data not shown). Antitumor activity of GlcNH 2 ⋅HCl in vivo Table 2 shows the antitumor activity of GlcNH 2 ⋅HCl in vivo. GlcNH 2 ⋅HCl at intermediate dose (250 mg/kg) had the highest inhibition ratio on Sarcoma 180 tumor growth and that the inhibition ratio declined at higher dose (500 mg/kg). GlcNH 2 ⋅HCl at dose of 250 mg/kg could also promote obviously the T lymphocyte proliferation induced by ConA, as well as the thymus index and spleen index. It suggests that GlcNH 2 ⋅HCl might enhance body immune function at a certain dose.
DISCUSSION
Studies showed that the antitumor activities of chitin and chitosan oligomers on the growth inhibition of tumor cells occurred via an immuno-enhancing effect (Tsukada et al., 1990) . The study reported herein revealed the direct inhibitory effects of GlcNH 2 ⋅HCl and GlcNH 2 on the proliferation of human hepatoma cell line SMMC-7721 in vitro might involve cell cycle arrest, though the exact mechanism of action is still unknown.
Glucosamine could be converted to uridine diphosphate-N-acetyl glucosamines. This sugar is used for O-linked glycosylation of several proteins, including chromatin proteins, transcription factors, nuclear pore proteins, and certain types of cytoskeletal proteins, leading to alteration in their biological activity (Kearse and Hart, 1991) . Furthermore, glucosamine has been demonstrated to play an important role in the detoxification of liver and kidney, and have biological activities such as liver-protecting and antimicrobial activities in vivo (Muzzarelli, 1993) . Such properties of glucosamine led us to hypothesize that hexosamine would be involved in the glycosylation of nucleoplasmic and cytoplasmic proteins, which is a regulatory modification (Reason et al., 1992) . In addition, our results are similar to those reported in other studies, which indicates that glucose and glucosamine could induce autocrine TGF-β activity (Kolm-Litty et al., 1998) .
The lack of inter-nucleosomal DNA degradation as shown in Fig.3 could suggest the occurrence of necrosis. However, the lower percentage of apoptotic cells could remain undetectable as DNA fragments in the gel electrophoretic analysis (Kosmider et al., 2004) . Borner et al.(1997) reported that an increase of membrane permeability would result in the loss of small DNA fragments. Ormerod et al.(1994) concluded that apoptotic cells would eventually undergo 'secondary' necrosis and the consequent non-specific degradation of their DNA would account for the slight smearing of the DNA upon gel electrophoresis. These suggest that apoptotic cell death did not require degradation of DNA into nucleosomal-sized fragments (Schulze-Osthoff et al., 1994; Bortner et al., 1995; Sakahira et al., 1999) .
Our investigation also revealed that NAG hardly showed any inhibitory effect on SMMC-7721 cells. It implies the NH 2 group or positive NH 2 group would be necessary for the inhibitory effect of glucosamine in vitro. A possible ionic interactions between the positively-charged NH 2 group in GlcNH 2 ⋅HCl and negatively-charged sialic acid residue on tumor cell surface would possibly result in a change in the ionic environment of the cell membrane, which is important in maintaining cell integrity and cell growth (Olsen et al., 1989; Santini et al., 1997; Schipper et al., 1996) . Thus, it is the lack of the amino group in NAG (Chandy and Sharma, 1990) . The real role of GlcNH 2 ⋅HCl in the body of tumor-bearing mice has remained unknown. The antitumor activity of GlcNH 2 ⋅HCl may be due to its cytocidal and immunomodulating properties. It was reported that the median lethal intravenous dose of GlcNH 2 ⋅HCl to a mouse is 1100 mg/kg (Ouyang et al., 2000) , which is much higher than the high dose of 500 mg/kg in our in vivo experiments. Borderline efficacy could be attributed to the highest inhibition ratio of medium dose, and doses between 250~500 mg/kg should be set to find the exact dose having the best antitumor activities in vivo. The pharmacokinetics of GlcNH 2 ⋅HCl in vivo should also be studied in further investigations.
It is known that apoptotic breakdown of cellular structures is largely mediated by caspases. Caspase-3 is involved in the cleavage of Nuclear Mitotic Apparatus protein and lamins either directly or by activating other proteases (Hengartner, 2000; Kivinen et al., 2005) . It can be detected at different stages of apoptosis. Hence, caspase-3 will be detected to clarify the plausible cellular mechanisms of the antiproliferative activity of GlcNH 2 ⋅HCl in our further study. The effect of GlcNH 2 ⋅HCl on immune function in tumorbearing mice will also be more investigated.
